anti-C1q and Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Antikörper

Probable adipokine. Zusätzlich bieten wir Ihnen C1q and Tumor Necrosis Factor Related Protein 9 Kits (20) und C1q and Tumor Necrosis Factor Related Protein 9 Proteine (8) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
C1QTNF9 338872 P0C862
C1QTNF9 239126 Q4ZJN1
C1QTNF9    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-C1q and Tumor Necrosis Factor Related Protein 9 Antikörper auf antikoerper-online.de

Showing 10 out of 31 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert ICC, IHC, WB Figure. Western Blot; Sample: Recombinant C1QTNF9, Human. Figure.DAB staining on IHC-P. Samples: Human Tissue 100 μg Anmelden zum Anzeigen 13 bis 16 Tage
$386.00
Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis using anti-CTRP9 (GD) (human), pAb  at 1:4'000 dilution. 1: Human CTRP9 (GD) (His-tagged). 100 μg Anmelden zum Anzeigen 5 bis 8 Tage
$327.75
Details
Human Kaninchen Unkonjugiert IHC, IHC (p), WB Immunohistochemistry: C1qTNF9 Antibody [NBP2-46834] - Analysis of human skeletal muscle shows strong cytoplasmic positivity in myocytes. Western Blot: C1qTNF9 Antibody [NBP2-46834] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10, Lane 2: Human cell line RT-4, Lane 3: Human cell line U-251 MG 0.1 mL Anmelden zum Anzeigen 10 bis 13 Tage
$491.63
Details
Human Maus Unkonjugiert IF, WB Western Blot analysis of C1QTNF9 expression in transfected 293T cell line by C1QTNF9 MaxPab polyclonal antibody.<br><br>Lane 1: MGC48915 transfected lysate(36.63 KDa).<br>Lane 2: Non-transfected lysate.<br> Immunofluorescence of <u>purified</u> MaxPab antibody to MGC48915 on HeLa cell. [antibody concentration 10 ug/ml] 50 μg Anmelden zum Anzeigen 11 bis 12 Tage
$440.00
Details
Human Maus Unkonjugiert IF, WB   50 μg Anmelden zum Anzeigen 7 bis 9 Tage
$837.83
Details
Human Meerschweinchen Unkonjugiert ELISA, WB   100 μg Anmelden zum Anzeigen 7 bis 9 Tage
$493.17
Details
Human Kaninchen Alexa Fluor 350 IF (p)   100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$405.90
Details
Human Kaninchen Alexa Fluor 555 IF (p)   100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$405.90
Details
Human Kaninchen Cy3 IF (p)   100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$405.90
Details
Human Kaninchen Cy5 IF (p)   100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$405.90
Details

C1QTNF9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human ,
, ,
,
, , , , , , , , , , , , ,
Mouse (Murine) ,


, , , , , , , , , , , , ,
Rat (Rattus) ,


, , , , , , , , , , , , ,

Weitere Antikörper gegen C1q and Tumor Necrosis Factor Related Protein 9 Interaktionspartner

Human C1q and Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Interaktionspartner

  1. CTRP9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating PRKAA1 (zeige PRKAA1 Antikörper).

  2. results revealed increased circulating levels of CTRP9 in T2DM and CAD (zeige CAD Antikörper) individuals which suggests a compensatory response to insulin (zeige INS Antikörper) resistance, inflammatory milieu and endothelial dysfunction; however, more studies are needed to confirm this

  3. CTRP9 levels are elevated in obesity and significantly decrease following weight loss surgery.

  4. Plasma CTRP9 levels are associated with atherosclerosis in diabetic patients without CKD, independently of obesity, adiponectin, and traditional cardiovascular risk factors

  5. The up-regulation of CTRP9 during hypertrophic heart disease facilitates maladaptive cardiac remodeling and left ventricular dysfunction.

  6. Results demonstrate that CTRP9 alleviates hepatic steatosis through relief of endoplasmic reticulum stress via the AMPK (zeige PRKAA1 Antikörper)-mediated induction of autophagy.

  7. Study demonstrates that CTRP9 attenuates cytokine-induced vascular inflammation in endothelial cells mediated by AMPK (zeige PRKAA1 Antikörper) activation.

  8. Circulating and coronary CTRP9 plays an important role in the inflammation and coronary atherosclerosis of CAD (zeige CAD Antikörper) patients. Serum CTRP9 is an independent protective factor of CAD (zeige CAD Antikörper)

  9. Serum CTRP9 concentration was significantly and positively associated with arterial stiffness in patients with type 2 diabetes

  10. Serum CTRP9 concentrations were positively associated with favorable glucose or metabolic phenotypes and absence of metabolic syndrome, independent of serum total adiponectin concentrations.

Mouse (Murine) C1q and Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Interaktionspartner

  1. CTRP9 is a cardiokine critical in maintaining a healthy microenvironment facilitating stem cell engraftment in infarcted myocardial tissue treated with mesenchymal stem cell transplantation.

  2. Based on these findings, this study showed that CTRP9 might induce mitochondrial biogenesis and protect high glucose-induced endothelial oxidative damage via AdipoR1-SIRT1-PGC-1alpha signaling pathway.

  3. These results suggested that gCTRP9 protected RAW 264.7 macrophages from oxLDL via AMPK (zeige PRKAA1 Antikörper) activation in an AdipoR1 (zeige ADIPOR1 Antikörper) dependent fashion.

  4. Suggest reduced plasma CTRP9 concentration during diabetes plays a causative role in platelet hyper-activity, contributing to platelet-induced cardiovascular damage.

  5. Results demonstrate that CTRP9 alleviates hepatic steatosis through relief of endoplasmic reticulum stress via the AMPK (zeige PRKAA1 Antikörper)-mediated induction of autophagy.

  6. Enhancing cardiac CTRP9 production and/or its proteolytic posttranslational modification are of therapeutic potential, attenuating diabetic cardiac injury.

  7. CTRP9 protects against acute cardiac damage in response to pathological stimuli by suppressing inflammatory reactions through AdipoR1 (zeige ADIPOR1 Antikörper)/AMPK (zeige PRKAA1 Antikörper)-dependent mechanisms.

  8. CTRP9 reduces pro-inflammatory cytokines expression in atherosclerotic plaque.

  9. Genetic evidence for a physiological role of CTRP9 in controlling energy balance via central and peripheral mechanisms.

  10. Adipokine CTRP9 attenuates adverse cardiac remodeling after acute myocardial infarction, largely via a protein kinase A (PKA)-dependent pathway.

C1q and Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Antigen-Profil

Protein Überblick

Probable adipokine. Activates AMPK, AKT, and p44/42 MAPK signaling pathways (By similarity).

Genbezeichner und Symbole assoziert mit C1QTNF9

  • C1q and TNF related 9 (C1QTNF9) Antikörper
  • C1q and tumor necrosis factor related protein 9 (C1qtnf9) Antikörper
  • 9130217G22Rik Antikörper
  • AQL1 Antikörper
  • C1QTNF9A Antikörper
  • Ciqtnf9 Antikörper
  • CTRP9 Antikörper

Bezeichner auf Proteinebene für C1QTNF9

complement C1q and tumor necrosis factor-related protein 9 , complement C1q and tumor necrosis factor-related protein 9A , complement C1q tumor necrosis factor-related protein 9 , complement C1q tumor necrosis factor-related protein 9A

GENE ID SPEZIES
338872 Homo sapiens
239126 Mus musculus
523616 Bos taurus
Ausgewählte Anbieter für anti-C1q and Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Antikörper
Haben Sie etwas anderes gesucht?